● We tripled our phase I activity with focus on psychiatry and neurology ● 28% increase in our pain business – migraine, OA and chronic pain ● Psychiatry still core therapeutic area with depression and schizophrenia leading the way in 2011 ● 70% of the total business was with CROs
Read More